Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay Brune

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
Nature Clinical Practice. Rheumatology|October 2, 2007
Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisalBurkhard Hinz, Bertold Renner, Kay Brune
Neuroscience Letters|November 13, 2007
Kinetics and functional characterization of the glycine receptor alpha2 and alpha3 subunitCornelia Heindl, Kay Brune, Bertold Renner
ALTEX|June 14, 2008
Refinement and reduction in animal experimentation: options for new imaging techniquesCornelia Heindl, Andreas Hess, Kay Brune
ALTEX|May 12, 2006
Hypoxia induced chemokine expression in nasal epithelial cells: development of an in vitro model for chronic rhinosinusitisAndreas Pahl, Stefan Szelenyi, Kay Brune
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 22, 2007
Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in manBurkhard Hinz, Olga Cheremina, Kay Brune
Current Rheumatology Reports|January 28, 2009
Aspirin and acetaminophen: should they be available over the counter?Kay Brune, Burkhard Hinz, Ivan Otterness
European Journal of Pain (London, England)|July 16, 2015
Authors' reply to letter by C. SteffenKay Brune, Bertold Renner, Gisa Tiegs
Advances in Experimental Medicine and Biology|May 20, 2003
Induction of COX-2 expression by the endocannabinoid derivative R(+)-methanandamideBurkhard Hinz, Robert Ramer, Kay Brune
Nature Reviews. Rheumatology|September 8, 2010
Using pharmacokinetic principles to optimize pain therapyKay Brune, Bertold Renner, Burkhard Hinz
Arthritis and Rheumatism|December 31, 2005
More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxibBurkhard Hinz, Harald Dormann, Kay Brune
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Nature Clinical Practice. Rheumatology|October 2, 2007
Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisalBurkhard Hinz, Bertold Renner, Kay Brune
Neuroscience Letters|November 13, 2007
Kinetics and functional characterization of the glycine receptor alpha2 and alpha3 subunitCornelia Heindl, Kay Brune, Bertold Renner
ALTEX|June 14, 2008
Refinement and reduction in animal experimentation: options for new imaging techniquesCornelia Heindl, Andreas Hess, Kay Brune
ALTEX|May 12, 2006
Hypoxia induced chemokine expression in nasal epithelial cells: development of an in vitro model for chronic rhinosinusitisAndreas Pahl, Stefan Szelenyi, Kay Brune
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 22, 2007
Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in manBurkhard Hinz, Olga Cheremina, Kay Brune
Current Rheumatology Reports|January 28, 2009
Aspirin and acetaminophen: should they be available over the counter?Kay Brune, Burkhard Hinz, Ivan Otterness
European Journal of Pain (London, England)|July 16, 2015
Authors' reply to letter by C. SteffenKay Brune, Bertold Renner, Gisa Tiegs
Advances in Experimental Medicine and Biology|May 20, 2003
Induction of COX-2 expression by the endocannabinoid derivative R(+)-methanandamideBurkhard Hinz, Robert Ramer, Kay Brune
Nature Reviews. Rheumatology|September 8, 2010
Using pharmacokinetic principles to optimize pain therapyKay Brune, Bertold Renner, Burkhard Hinz
Arthritis and Rheumatism|December 31, 2005
More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxibBurkhard Hinz, Harald Dormann, Kay Brune
Pageof 11